Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome

BACKGROUND: The drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome represents a severe hypersensitivity reaction. Up-to-date treatment is based on withdrawal of medication, supportive care, and immunosuppression using high-dose corticosteroid (CS) therapy. However, evidence-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubin, Limor, Talmon, Aviv, Ribak, Yaarit, Kessler, Asa, Martin, Yossi, Haran, Tal Keidar, Shamriz, Oded, Adini, Irit, Tal, Yuval
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175640/
https://www.ncbi.nlm.nih.gov/pubmed/37187735
http://dx.doi.org/10.3389/fimmu.2023.1134178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175640/
https://www.ncbi.nlm.nih.gov/pubmed/37187735
http://dx.doi.org/10.3389/fimmu.2023.1134178

Ejemplares similares